BACKGROUND: Telephone interviews are widely used in geriatric settings to identify eligible research participants and to perform brief follow-up assessments of cognition. This article reports on the development and validation of the Memory and Aging Telephone Screen (MATS), a structured interview for older adults with mild cognitive impairment and/or significant memory complaints. We also developed three alternate forms of the MATS objective memory test to reduce practice effects engendered by multiple administrations. METHODS: Participants were enrolled in a longitudinal study that included 120 older adults with amnestic mild cognitive impairment, subjective cognitive complaints but without deficit on neuropsychological tests, and demographically matched healthy controls. An additional 15 patients with mild probable Alzheimer's disease completed the alternative forms study. All participants received the original MATS version, and a subset (n = 90) later received two of three alternate forms. RESULTS: The MATS was sensitive to group differences, and the alternate forms were equivalent. MATS objective memory test scores showed adequate stability during a period of 1 year and were moderately correlated with scores on a widely used list-learning test (California Verbal Learning Test, Second Edition). CONCLUSIONS: The MATS, a repeatable telephone screen that includes objective and subjective memory assessments, is useful for detecting individuals in the preclinical and early stages of dementia. Results encourage use of the MATS as a reliable and valid cognitive screening tool in research and clinical settings. Longitudinal assessments are being performed to investigate the predictive validity of the MATS for cognitive progression in mild cognitive impairment.
BACKGROUND: Telephone interviews are widely used in geriatric settings to identify eligible research participants and to perform brief follow-up assessments of cognition. This article reports on the development and validation of the Memory and Aging Telephone Screen (MATS), a structured interview for older adults with mild cognitive impairment and/or significant memory complaints. We also developed three alternate forms of the MATS objective memory test to reduce practice effects engendered by multiple administrations. METHODS:Participants were enrolled in a longitudinal study that included 120 older adults with amnestic mild cognitive impairment, subjective cognitive complaints but without deficit on neuropsychological tests, and demographically matched healthy controls. An additional 15 patients with mild probable Alzheimer's disease completed the alternative forms study. All participants received the original MATS version, and a subset (n = 90) later received two of three alternate forms. RESULTS: The MATS was sensitive to group differences, and the alternate forms were equivalent. MATS objective memory test scores showed adequate stability during a period of 1 year and were moderately correlated with scores on a widely used list-learning test (California Verbal Learning Test, Second Edition). CONCLUSIONS: The MATS, a repeatable telephone screen that includes objective and subjective memory assessments, is useful for detecting individuals in the preclinical and early stages of dementia. Results encourage use of the MATS as a reliable and valid cognitive screening tool in research and clinical settings. Longitudinal assessments are being performed to investigate the predictive validity of the MATS for cognitive progression in mild cognitive impairment.
Authors: Margaret Gatz; Chandra A Reynolds; Richard John; Boo Johansson; James A Mortimer; Nancy L Pedersen Journal: Int Psychogeriatr Date: 2002-09 Impact factor: 3.878
Authors: A J Saykin; H A Wishart; L A Rabin; R B Santulli; L A Flashman; J D West; T L McHugh; A C Mamourian Journal: Neurology Date: 2006-09-12 Impact factor: 9.910
Authors: Nia White; Anne Scott; Robert T Woods; G Clare Wenger; John D Keady; Manikkarasa Devakumar Journal: Br J Gen Pract Date: 2002-12 Impact factor: 5.386
Authors: Laura A Rabin; Colette M Smart; Paul K Crane; Rebecca E Amariglio; Lorin M Berman; Mercé Boada; Rachel F Buckley; Gaël Chételat; Bruno Dubois; Kathryn A Ellis; Katherine A Gifford; Angela L Jefferson; Frank Jessen; Mindy J Katz; Richard B Lipton; Tobias Luck; Paul Maruff; Michelle M Mielke; José Luis Molinuevo; Farnia Naeem; Audrey Perrotin; Ronald C Petersen; Lorena Rami; Barry Reisberg; Dorene M Rentz; Steffi G Riedel-Heller; Shannon L Risacher; Octavio Rodriguez; Perminder S Sachdev; Andrew J Saykin; Melissa J Slavin; Beth E Snitz; Reisa A Sperling; Caroline Tandetnik; Wiesje M van der Flier; Michael Wagner; Steffen Wolfsgruber; Sietske A M Sikkes Journal: J Alzheimers Dis Date: 2015-09-24 Impact factor: 4.472
Authors: Katherine E Nutter-Upham; Andrew J Saykin; Laura A Rabin; Robert M Roth; Heather A Wishart; Nadia Pare; Laura A Flashman Journal: Arch Clin Neuropsychol Date: 2008-03-12 Impact factor: 2.813
Authors: Mark A Espeland; Stephen R Rapp; Jeff A Katula; Lee Ann Andrews; Deborah Felton; Sarah A Gaussoin; Dale Dagenbach; Claudine Legault; Janine M Jennings; Kaycee M Sink Journal: Int J Geriatr Psychiatry Date: 2011-02 Impact factor: 3.485
Authors: Robert S Wilson; Sue E Leurgans; Tatiana M Foroud; Robert A Sweet; Neill Graff-Radford; Richard Mayeux; David A Bennett Journal: Arch Neurol Date: 2010-07
Authors: Laura A Rabin; Nadia Paré; Andrew J Saykin; Michael J Brown; Heather A Wishart; Laura A Flashman; Robert B Santulli Journal: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn Date: 2009-04-07
Authors: Teresa C Castanho; Liliana Amorim; Joseph Zihl; Joana A Palha; Nuno Sousa; Nadine C Santos Journal: Front Aging Neurosci Date: 2014-02-25 Impact factor: 5.750
Authors: Shannon L Risacher; Yang Wang; Heather A Wishart; Laura A Rabin; Laura A Flashman; Brenna C McDonald; John D West; Robert B Santulli; Andrew J Saykin Journal: Front Psychiatry Date: 2013-09-17 Impact factor: 4.157
Authors: Anne R Carlew; Hudaisa Fatima; Julia R Livingstone; Caitlin Reese; Laura Lacritz; Cody Pendergrass; Kenneth Chase Bailey; Chase Presley; Ben Mokhtari; Colin Munro Cullum Journal: Arch Clin Neuropsychol Date: 2020-11-19 Impact factor: 2.813